Can Lyrica (pregabalin) cause stuttering?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Does Lyrica Cause Stuttering?

Lyrica (pregabalin) is not documented to cause stuttering as a side effect in any FDA-approved labeling, clinical guidelines, or high-quality clinical trials. The most common neurological side effects are dizziness (23-46%), somnolence (15-25%), confusion, and coordination abnormalities, but stuttering is not among them 1.

Evidence-Based Side Effect Profile

The established adverse effects of pregabalin affecting speech and neurological function include:

  • Dizziness and somnolence are the predominant dose-dependent neurological effects, occurring in nearly half of patients at higher doses 1, 2
  • Confusion, balance disorders, tremor, and coordination abnormalities are documented, particularly in elderly patients 1
  • Mental status changes and cognitive impairment can occur, especially with accumulation in renal impairment 3
  • Slowed comprehension and decreased alertness may develop with chronic use 3

Distinguishing Functional Stuttering from Drug Effects

If a patient develops new-onset stuttering while taking pregabalin, consider functional stuttering as an alternative diagnosis, which is characterized by 4:

  • New onset in adulthood without prior developmental speech difficulties
  • Extremes of variability or unusual consistency (stuttering on every syllable/word)
  • Increased dysfluency with simple speech tasks rather than complex ones
  • Lack of improvement with activities that usually promote fluency
  • May follow stressful life events or occur with other functional neurological symptoms

Clinical Approach to New Speech Problems on Pregabalin

Evaluate for pregabalin-related cognitive impairment rather than stuttering specifically:

  • Check renal function immediately - pregabalin is 95% renally excreted and accumulation causes mental status changes requiring dose reduction of 50-90% based on creatinine clearance 1, 3
  • Assess for excessive sedation - confusion and slowed comprehension can affect speech fluency without causing true stuttering 3
  • Review total medication burden - combining pregabalin with opioids, benzodiazepines, or other CNS depressants causes synergistic sedative effects 1
  • Consider diagnostic trial - temporary dose reduction or discontinuation (tapered over minimum 1 week) can clarify if symptoms are medication-related 1, 3

Critical Pitfall to Avoid

Do not attribute true stuttering to pregabalin without ruling out functional neurological disorder or other causes. The extensive clinical trial data and post-marketing surveillance for pregabalin, which includes detailed adverse event reporting across multiple indications (neuropathic pain, epilepsy, anxiety), does not identify stuttering as a recognized side effect 2, 5, 6. If speech disruption occurs, it is more likely related to general cognitive slowing, sedation, or an independent functional disorder rather than a direct pharmacological effect on speech motor control 4, 3.

References

Guideline

Pregabalin Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Mental Status Changes Associated with Lyrica (Pregabalin)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pregabalin: a new agent for the treatment of neuropathic pain.

Drugs of today (Barcelona, Spain : 1998), 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.